Corcept Therapeutics (CORT) President of Oncology Vieira Sells 296 Shares

What Happened

• Roberto Vieira Wandenkolk, President, Oncology at Corcept Therapeutics (CORT), sold 296 shares on 2026-09-16 at $100.82 per share, for a total of approximately $29,843. This was a sale (not a purchase).

Key Details

• Transaction date and price: 2026-09-16 — 296 shares sold at $100.82 each (total ~$29,843).
• Filing: Form 4 filed 2026-09-18 (two days after the reported transaction).
• Shares owned after transaction: not specified in the filing.
• Notable footnotes:
  • F1: The sale was made under a prearranged 10b5-1 trading plan adopted June 17, 2026 (the plan was in effect at the time of this sale).
  • F2: The reporting person holds unvested restricted stock awards totaling 1,347 shares (179 + 396 + 634 + 138). These awards vest 100% on each grant’s one-year anniversary if vesting conditions are met.
• Signature/authority: Form signed under a power of attorney on file with the SEC.

Context

• Sales executed under 10b5-1 plans are prearranged trades that can occur regardless of material nonpublic information; they are typically routine and do not by themselves indicate the insider’s view of the company’s prospects.
• This was a straightforward open-market sale, not an option exercise, gift, or tax-withholding transaction.